Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa

被引：20
作者：
Sugg, R. M. [1 ]
Gonzales, N. R. [1 ]
Matherne, D. E. [1 ]
Ribo, M. [1 ]
Shaltoni, H. M. [1 ]
Baraniuk, S. [1 ]
Noser, E. A. [1 ]
Grotta, J. C. [1 ]
机构：
[1] Univ Texas, Sch Med, Dept Neurol, Houston, TX USA
来源：
NEUROLOGY | 2006年 / 67卷 / 06期
关键词：
D O I：
10.1212/01.wnl.0000239154.51331.c4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We report myocardial injury in 20 recombinant factor VIIa ( rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated ( p = 0.02). Myocardial infarction occurred in 10% vs 1% ( p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
引用
收藏
页码：1053 / 1055
页数：3
相关论文
共 10 条
[1]   Serum cardiac troponin T levels as an indicator of myocardial injury in ischemic and hemorrhagic stroke patients [J].
Apak, I ;
Iltumur, K ;
Taman, Y ;
Kaya, N .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 205 (02) :93-101
[2]   Creatine kinase-MB elevation after stroke is not cardiac in origin - Comparison with troponin T levels [J].
Ay, H ;
Arsava, EM ;
Saribas, O .
STROKE, 2002, 33 (01) :286-289
[3]   Guidelines for the management of spontaneous intracerebral hemorrhage - A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association [J].
Broderick, JP ;
Adams, HP ;
Barsan, W ;
Feinberg, W ;
Feldmann, E ;
Grotta, J ;
Kase, C ;
Krieger, D ;
Mayberg, M ;
Tilley, B ;
Zabramski, JM ;
Zuccarello, M .
STROKE, 1999, 30 (04) :905-915
[4]   Early hemorrhage growth in patients with intracerebral hemorrhage [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
Barsan, W ;
Tomsick, T ;
Sauerbeck, L ;
Spilker, J ;
Duldner, J ;
Khoury, J .
STROKE, 1997, 28 (01) :1-5
[5]   Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors [J].
Hough, RE ;
Hampton, KK ;
Preston, FE ;
Channer, KS ;
West, J ;
Makris, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (03) :974-979
[6]   Recombinant activated factor VII for acute intracerebral hemorrhage [J].
Mayer, SA ;
Brun, NC ;
Begtrup, K ;
Broderick, J ;
Davis, S ;
Diringer, MN ;
Skolnick, BE ;
Steiner, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :777-785
[7]   Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage [J].
Mayer, SA ;
Brun, NC ;
Broderick, J ;
Davis, S ;
Diringer, MN ;
Skolnick, BE ;
Steiner, T .
STROKE, 2005, 36 (01) :74-79
[8]  
*NOV, 2005, NOV
[9]   Thromboembolic adverse events after use of recombinant human coagulation factor VIIa [J].
O'Connell, KA ;
Wood, JJ ;
Wise, RP ;
Lozier, JN ;
Braun, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (03) :293-298
[10]   Medical progress: Spontaneous intracerebral hemorrhage. [J].
Qureshi, AI ;
Tuhrim, S ;
Broderick, JP ;
Batjer, HH ;
Hondo, H ;
Hanley, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (19) :1450-1460
1